Our Services
Medical Information
Helpful Resources
Published on: 10/1/2026
Mono, or infectious mononucleosis, is a viral illness usually caused by the Epstein-Barr virus and marked by extreme fatigue, sore throat, swollen lymph nodes, and fever. It spreads mainly through saliva and close contact such as kissing or sharing drinks, utensils, and toothbrushes, with symptoms often appearing four to six weeks after exposure. Most people improve within two to four weeks, but fatigue and spleen enlargement can linger for one to several months, and important details about contagious periods, activity restrictions, and complications are explained below. Because mono closely mimics strep throat, flu, and other infections, the full answer below outlines which symptoms deserve urgent attention and why.
Since fatigue and a sore throat can point to many different conditions, a free, instant, online symptom check can help you compare your specific symptoms against possible causes in minutes, so you walk into your next appointment with clearer questions and a smarter plan.
Last reviewed for medical accuracy: 10/01/2025
Infectious mononucleosis—commonly called “mono”—is a viral infection most often caused by the Epstein-Barr virus (EBV). It’s sometimes nicknamed the “kissing disease” because it spreads through saliva, but there’s more to know than just that. Below, we’ll explain what mono is, how you catch it, how long it typically lasts, and when you should talk to a healthcare professional.
Mono is an infection that mainly affects teenagers and young adults, though people of any age can get it. Key points:
Typical signs and symptoms include:
Most people develop immunity to EBV after infection, so repeat mono is rare.
Mono spreads primarily through contact with saliva, but it can also move via other bodily fluids. Common routes of transmission include:
Because EBV can remain in saliva for weeks after symptoms fade, you might still be contagious even when you feel better. Young children often carry the virus without noticeable symptoms, so adults can pick it up from household contacts without realizing it.
After infection, symptoms usually appear in:
This delay means you may not know you’ve been exposed until well after the contact occurred.
While individual experiences vary, the general timeline looks like this:
Prodrome (early phase)
Acute phase
Recovery phase
Total duration from first symptom to full recovery: approximately 2–3 months for most people. A small percentage experience fatigue or mild symptoms for up to 6 months.
There’s no specific antiviral that cures mono; treatment focuses on relieving symptoms:
If you suspect mono, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to get guidance tailored to your signs and risks.
Most mono cases resolve without complications. However, seek medical advice if you experience:
Always talk to a healthcare professional if you’re worried about life-threatening or serious symptoms.
Though uncommon, mono can lead to:
Most people do not experience these complications, but it’s important to monitor your symptoms and follow up with your doctor.
Since there’s no vaccine for EBV, prevention centers on reducing saliva exposure:
These simple steps can lower your risk of catching or passing on EBV.
If fatigue or other symptoms persist beyond a few months, follow up with your healthcare provider for evaluation.
While mono is usually self-limiting, always discuss any serious or prolonged symptoms with your physician. They can:
By understanding what mono is, how you catch it, and how long it lasts, you can take steps to manage your recovery and protect others. Always consult a healthcare professional for personalized medical advice.
(References)
* Blazej LJ, Cohen-Goldberg AM. Can we hear morphological complexity before words are complex? J Exp Psychol Hum Percept Perform. 2015 Feb;41(1):50-68. doi: 10.1037/a0038509. Epub 2014 Dec 15. PMID: 25494654.
* Manrique P, Miranda-Alban J, Alarcon-Baldeon J, Ramirez R, Carrasco-Escobar G, Herrera H, Guzman-Guzman M, Rosas-Aguirre A, Llanos-Cuentas A, Vinetz JM, Escalante AA, Gamboa D. Microsatellite analysis reveals connectivity among geographically distant transmission zones of Plasmodium vivax in the Peruvian Amazon: A critical barrier to regional malaria elimination. PLoS Negl Trop Dis. 2019 Nov;13(11):e0007876. doi: 10.1371/journal.pntd.0007876. Epub 2019 Nov 11. PMID: 31710604; PMCID: PMC6874088.
* Sikder AK, Pandey KS, Jaiswal DK, Dube SN, Kumar D, Husain K, Bhattacharya R, Das Gupta S. The 3,3'-bis-pyridinium mono-oximes as antidotes against organophosphorous intoxication. J Pharm Pharmacol. 1992 Dec;44(12):1038-40. PMID: 1361555.
* Kittayapong P, Clark JM, Edman JD, Potter TL, Lavine BK, Marion JR, Brooks M. Cuticular lipid differences between the malaria vector and non-vector forms of the Anopheles maculatus complex. Med Vet Entomol. 1990 Oct;4(4):405-13. doi: 10.1111/j.1365-2915.1990.tb00458.x. PMID: 2133007.
* Setti G, Calciolari CA, Cimino V, Zanini A, Sarzi Puttini P. The treatment of idiopathic and secondary hydrarthrosis of the knee by intra-articular Rifamycin SV. Chir Organi Mov. 1990 Oct-Dec;75(4):343-6. PMID: 2098221.
* Gorelikov PL. [Functional changes in the chromatophilic substance and RNA content of the cytoplasm of sympathetic neurons in the presence of synaptic transmission disorders]. Arkh Anat Gistol Embriol. 1981 Jul;81(7):58-64. PMID: 6170279.
* Arends JE, Lieveld FI, Boeijen LL, de Kanter CT, van Erpecum KJ, Salmon D, Hoepelman AI, Asselah T, Ustianowski A. Natural history and treatment of HCV/HIV coinfection: Is it time to change paradigms? J Hepatol. 2015 Nov;63(5):1254-62. doi: 10.1016/j.jhep.2015.06.034. Epub 2015 Jul 14. PMID: 26186987.
* Del Vecchio M. [AACR update on 5-year survival rates, efficacy and long-term safety in previously treated advanced/metastatic melanoma patients receiving mono-immunotherapy with nivolumab]. Recenti Prog Med. 2016 Aug;107(8):414-7. doi: 10.1701/2332.25062. PMID: 27571556.
* VERLINDE JD, de SONNAVILLE LM, MAKSTENIEKS O. Experimental transmission of infectious mononucleosis to monkeys, and the hemagglutination of erythrocytes treated with Newcastle Disease virus. Antonie Van Leeuwenhoek. 1950;16(1):21-30. doi: 10.1007/BF02274396. PMID: 15419634.
* ABRAMS HL. Infectious mononucleosis with intense jaundice of long duration. N Engl J Med. 1948 Feb 26;238(9):295-7. doi: 10.1056/NEJM194802262380906. PMID: 18900499.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.